These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 19846344

  • 21. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.
    Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
    [Abstract] [Full Text] [Related]

  • 22. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS, Koldingsnes W, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.
    Arthritis Rheum; 2008 Feb 15; 59(2):234-40. PubMed ID: 18240258
    [Abstract] [Full Text] [Related]

  • 23. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep 15; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 24. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.
    Int J Rheum Dis; 2012 Jun 15; 15(3):330-5. PubMed ID: 22709496
    [Abstract] [Full Text] [Related]

  • 25. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L.
    Arthritis Rheum; 2009 Nov 15; 60(11):3180-9. PubMed ID: 19877027
    [Abstract] [Full Text] [Related]

  • 26. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.
    Vaccine; 2011 Feb 11; 29(8):1643-8. PubMed ID: 21211590
    [Abstract] [Full Text] [Related]

  • 27. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
    Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A.
    Arthritis Rheum; 2008 Mar 11; 58(3):667-77. PubMed ID: 18311816
    [Abstract] [Full Text] [Related]

  • 28. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
    Söderlin MK, Petersson IF, Geborek P.
    Scand J Rheumatol; 2012 Feb 11; 41(1):1-9. PubMed ID: 22118371
    [Abstract] [Full Text] [Related]

  • 29. Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.
    Blom M, Kievit W, Donders AR, den Broeder AA, Straten VH, Kuper I, Visser H, Jansen TL, Brus HL, Branten AJ, van de Laar MA, van Riel PL.
    J Rheumatol; 2011 Nov 11; 38(11):2355-61. PubMed ID: 21885487
    [Abstract] [Full Text] [Related]

  • 30. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
    Savioli C, Ribeiro AC, Fabri GM, Calich AL, Carvalho J, Silva CA, Viana VS, Bonfá E, Siqueira JT.
    J Clin Rheumatol; 2012 Jun 11; 18(4):180-4. PubMed ID: 22647860
    [Abstract] [Full Text] [Related]

  • 31. The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept.
    Jamnitski A, Bartelds GM, Nurmohamed MT, van Schouwenburg PA, van Schaardenburg D, Stapel SO, Dijkmans BA, Aarden L, Wolbink GJ.
    Ann Rheum Dis; 2011 Feb 11; 70(2):284-8. PubMed ID: 21068090
    [Abstract] [Full Text] [Related]

  • 32. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
    Cepeda EJ, Williams FM, Ishimori ML, Weisman MH, Reveille JD.
    Ann Rheum Dis; 2008 May 11; 67(5):710-2. PubMed ID: 18079191
    [Abstract] [Full Text] [Related]

  • 33. Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Park JK, Lee MA, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB.
    Ann Rheum Dis; 2017 Sep 11; 76(9):1559-1565. PubMed ID: 28468794
    [Abstract] [Full Text] [Related]

  • 34. Anti-Ro/SSA antibodies are an independent factor associated with an insufficient response to tumor necrosis factor inhibitors in patients with rheumatoid arthritis.
    Matsudaira R, Tamura N, Sekiya F, Ogasawara M, Yamanaka K, Takasaki Y.
    J Rheumatol; 2011 Nov 11; 38(11):2346-54. PubMed ID: 21965648
    [Abstract] [Full Text] [Related]

  • 35. Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.
    Gabay C, Bel M, Combescure C, Ribi C, Meier S, Posfay-Barbe K, Grillet S, Seebach JD, Kaiser L, Wunderli W, Guerne PA, Siegrist CA, H1N1 Study Group.
    Arthritis Rheum; 2011 Jun 11; 63(6):1486-96. PubMed ID: 21384334
    [Abstract] [Full Text] [Related]

  • 36. Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.
    Ollendorf DA, Klingman D, Hazard E, Ray S.
    Clin Ther; 2009 Apr 11; 31(4):825-35. PubMed ID: 19446156
    [Abstract] [Full Text] [Related]

  • 37. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML.
    Dan Med Bull; 2011 Nov 11; 58(11):B4320. PubMed ID: 22047935
    [Abstract] [Full Text] [Related]

  • 38. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.
    Woerner A, Sauvain MJ, Aebi C, Otth M, Bolt IB.
    Hum Vaccin; 2011 Dec 11; 7(12):1293-8. PubMed ID: 22185812
    [Abstract] [Full Text] [Related]

  • 39. Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis.
    Dejaco C, Duftner C, Klotz W, Schirmer M, Herold M.
    Scand J Rheumatol; 2009 Dec 11; 38(1):66-7. PubMed ID: 18759163
    [No Abstract] [Full Text] [Related]

  • 40. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.
    Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H, Nakajima A, Saito K, Takeno M, Atsumi T, Tohma S, Ito S, Tamura N, Fujii T, Sawada T, Ida H, Hashiramoto A, Koike T, Ishigatsubo Y, Eguchi K, Tanaka Y, Takeuchi T, Miyasaka N, Harigai M, REAL Study Group.
    J Rheumatol; 2011 Jul 11; 38(7):1258-64. PubMed ID: 21498482
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.